Plasma proteomic analysis shows differential protein abundance in irradiated BALB/c mice, suggesting treatment influences cancer progression.
Differential plasma protein abundance as a function of treatment and time. Unsupervised clustering of plasma protein abundance annotated for treatment group [control, aspirin (ASP), IR, and IR + aspirin] and time of post-transplantation (4, 8, and 18 months) of tumor free and TB mice. The key pathway enrichment of proteins in the four clades is indicated in the sidebar. Unsupervised clustering using Euclidian distance and Ward.D.2.
No takes yet. Share an insight, caveat, or question.
Akbarzadeh et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: